2024
Clonal cytopenia of undetermined significance: definitions, risk and therapeutic targets
Taborda C, Zeidan A, Mendez L. Clonal cytopenia of undetermined significance: definitions, risk and therapeutic targets. Frontiers In Hematology 2024, 3: 1419323. DOI: 10.3389/frhem.2024.1419323.Peer-Reviewed Original ResearchClonal hematopoiesis of indeterminate potentialClonal hematopoiesisClonal cytopeniaSomatic genetic alterationsTherapeutic targetStem/progenitor cell populationsRisk stratification toolBlood of individualsMyeloid malignanciesMyeloid neoplasmsHematologic malignanciesPotential therapeutic targetIndeterminate potentialRisk stratificationBlood countGenetic alterationsStratification toolClinical investigationNatural historyCell populationsCytopeniasMalignancyBloodRiskCytopenia(s
2015
Myelodysplastic syndromes: from conductiong clinical trials of novel therapies to evaluating real-life effectiveness of exisiting therapies
Zeidan A. Myelodysplastic syndromes: from conductiong clinical trials of novel therapies to evaluating real-life effectiveness of exisiting therapies. International Journal Of Hematologic Oncology 2015, 4: 215-217. DOI: 10.2217/ijh.15.25.Peer-Reviewed Original ResearchMyelodysplastic syndromeHematologic malignanciesNovel therapiesYale Cancer CenterReal-life effectivenessMyeloid hematologic malignanciesHematology/oncology fellowshipRochester General HospitalInternal medicine residencyCancer CenterClinical trialsGeneral HospitalClinical investigationFaculty of MedicineOncology fellowshipsMalignancyTherapyClinical interestTranslational researchMedicine residencyOutcomes researchMBBS degreeMedicineJohns Hopkins UniversityResearch Fellowship